<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title>Frontiers in Genetics</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Genet.</abbrev-journal-title>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1079739</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2022.1079739</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Inflammation-related pathways involved in damaged articular cartilage of rats exposed to T-2 toxin based on RNA-sequencing analysis</article-title>
<alt-title alt-title-type="left-running-head">Shi et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fgene.2022.1079739">10.3389/fgene.2022.1079739</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Shi</surname>
<given-names>Longyan</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/2064920/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Qiuliang</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Heying</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Qi</given-names>
</name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Jiaxiang</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1738808/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Fan</surname>
<given-names>Yingzhong</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
</contrib-group>
<aff>
<institution>Department of Pediatric Surgery</institution>, <institution>First Affiliated Hospital of Zhengzhou University</institution>, <addr-line>Zhengzhou</addr-line>, <addr-line>Henan</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1873370/overview">Lu Qiao</ext-link>, Seoul National University, South Korea</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2072484/overview">Jin Dai</ext-link>, Children&#x2019;s Hospital of Soochow University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1473676/overview">Xi Wang</ext-link>, Xi&#x2019;an Jiaotong University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Jiaxiang Wang, <email>wjiaxiang@zzu.edu.cn</email>; Yingzhong Fan, <email>zdyfyxew@126.com</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Human and Medical Genomics, a section of the journal Frontiers in Genetics</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>12</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>1079739</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>10</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>11</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Shi, Liu, Yang, Wang, Wang and Fan.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Shi, Liu, Yang, Wang, Wang and Fan</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Many studies have shown that ingestion of the T-2 toxin is harmful to articular cartilage. However, the mechanisms underlying damaged articular cartilage induced by T-2 toxin have not been elucidated. Twenty-four SD rats were randomly divided into T-2 toxin and control groups. In the control group, the 12 rats were administered 4% absolute ethanol by gavage, and in the T-2 toxin group, the 12 rats were administered T-2 toxin (100&#xa0;ng/g, BW/day) by gavage. After the rats were sacrificed, the knee joints were collected, and RNA was extracted using TRIzol reagent for RNA sequencing (RNA-seq). Differentially expressed mRNA was identified based on <italic>p</italic> &#x3c; 0.05 and &#x7c; log<sub>2</sub> (fold change) &#x7c; &#x3e; 1. The T-2 toxin-related genes were obtained from the GeneCards database. An online tool (<ext-link ext-link-type="uri" xlink:href="https://www.bioinformatics.com.cn">https://www.bioinformatics.com.cn</ext-link>) was used for enrichment analysis. Hematoxylin and eosin (H&#x26;E) staining was used to observe damaged articular cartilage, and immunohistochemical (IHC) staining was used to validate differentially expressed proteins. The H&#x26;E staining shows the number of cells decreased significantly, and the arrangement of chondrocytes became disordered in the T-2 toxin group. RNA-seq analysis identified 195 upregulated and 89 downregulated mRNAs in the T-2 toxin group. The top immune-related biological processes (Gene Ontology) were regulation of hormone secretion, regulation of peptide hormone secretion, and regulation of transcription involved in cell fate commitment. KEGG pathway enrichment analysis revealed that the IL-17 and tumor necrosis factor signaling pathways were significantly expressed, and the IL-17 signaling pathway was also identified in the enrichment analysis of T-2 toxin-related genes. Also, Mmp3, Tnf, Mapk10, Ccl11, Creb5, Cxcl2, and Cebpb were significantly enriched in the two pathways. The immunohistochemical staining showed that the levels of Mmp3 and Tnf proteins were significantly increased in the T-2 toxin group, which was consistent with the RNA-seq results. This study revealed the critical roles of IL-17 and TNF signaling pathways in damaged cartilage induced by T-2 toxin.</p>
</abstract>
<kwd-group>
<kwd>T-2 toxin</kwd>
<kwd>articular cartilage</kwd>
<kwd>inflammatory response</kwd>
<kwd>RNA-seq</kwd>
<kwd>IL-17 signaling pathway</kwd>
<kwd>TNF signaling pathway</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>The T-2 toxin is the most toxic class A trichothecene mycotoxin produced by <italic>Fusarium</italic>. It is widely distributed in nature and mainly contaminates cereals and grains, such as wheat, barley, oats, rice, maize, and sorghum, and is harmful to humans and poultry. At present, it is believed that the T-2 toxin can cause a variety of human and animal diseases such as alimentary toxic aleukia and Kashin&#x2013;Beck disease (KBD) (<xref ref-type="bibr" rid="B22">Lutsky et al., 1978</xref>; <xref ref-type="bibr" rid="B13">Li et al., 2016</xref>). The Soviet Union scholar proposed the hypothesis of food mycotoxin contamination in 1964, and the causative organism was considered to be a toxigenic strain of <italic>Fusarium sporotrichiella. var. poae Bilai</italic> (<xref ref-type="bibr" rid="B29">Sokoloff, 1988</xref>). The rats fed with <italic>Fusarium</italic> showed epiphyseal lesions and femur shortening, while the rats in the control group developed normally (<xref ref-type="bibr" rid="B9">Guo et al., 2014</xref>). In 1990s, Yang Jianbo proposed a relationship between the T-2 toxin and KBD according to epidemiological investigations (Dianjun Sun; <xref ref-type="bibr" rid="B31">Wang et al., 2020</xref>). In 1995, he investigated edible grains of severe KBD areas in Shaanxi and Sichuan provinces and the commercially available grains in non-KBD areas from Henan, Hubei, Hunan, and Guangxi provinces. The results showed the concentration of T-2 toxin (ranging from 2.0 to 1,549.4&#xa0;ng/g) in 10 out of 15 family-grown flour samples in the KBD areas was positive, which was significantly higher than that of the commercial flour samples in non-KBD areas (ranging from 2.0 to 885.3&#xa0;ng/g). Meanwhile, the study also confirmed the threshold concentration of T-2 toxin in flour should not exceed 300&#xa0;ng/g (<xref ref-type="bibr" rid="B36">Yang et al., 1995</xref>). Therefore, the concentration of T-2 toxin in the flour and corn meal of families affected by KBD resulted in an abnormal aggregation phenomenon.</p>
<p>According to the food mycotoxin contamination hypothesis, the grain harvest season is rainy, and thus, fungi contaminate the grain during harvesting, drying, and storage. As healthy children in the KBD areas consumed fungus-contaminated grains, the T-2 toxin selectively damaged the developing articular cartilage, resulting in damage to the membrane system of chondrocytes, inhibition of DNA synthesis, and induction of chondrocytes apoptosis (<xref ref-type="bibr" rid="B9">Guo et al., 2014</xref>). When chondrocytes were incubated with T-2 toxin, the growth rate decreased, the protein and DNA contents were reduced, levels of collagen II and proteoglycan decreased, expression of matrix metalloproteinase 13 increased, and chondrocyte apoptosis was induced (<xref ref-type="bibr" rid="B20">Liu et al., 2021</xref>; <xref ref-type="bibr" rid="B14">Li H. N. et al., 2022</xref>). When the chicks were fed diets containing T-2 toxin for 5&#xa0;weeks, their articular cartilage underwent degenerative changes, which caused deep necrosis of the epiphyseal plate cartilage (<xref ref-type="bibr" rid="B38">Yu et al., 2022</xref>). Wistar rats were treated with T-2 toxin (100&#xa0;ng/kg) for 10&#xa0;months, and the results showed chondrocyte degeneration/necrosis and loss, chondrocyte clones, and loss of proteoglycan staining of articular cartilage in the femorotibial cartilage. The rats exposed to T-2 toxin showed degenerative lesions in articular cartilage similar to spontaneous osteoarthritis (<xref ref-type="bibr" rid="B32">Wang et al., 2011</xref>; <xref ref-type="bibr" rid="B38">Yu et al., 2022</xref>). However, the deep necrosis of articular cartilage in human KBD has not been replicated.</p>
<p>A previous study examined the DNA methylation dynamics of human chondrocytes treated with T-2 toxin and found that the dysfunction of the MAPK pathway was involved in the damaged human chondrocyte (<xref ref-type="bibr" rid="B37">Yang et al., 2022</xref>). However, previous studies have only been performed at the cellular level and have not been validated in cartilage tissues. In this study, SD rats were treated with T-2 toxin (100&#xa0;ng/g) for 4&#xa0;weeks, and the articular cartilage tissues were collected. RNA transcription sequencing technology was used to explore the mechanism of damaged articular cartilage induced by the T-2 toxin.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Methods and materials</title>
<sec id="s2-1">
<title>Establishment and treatment of animal model</title>
<p>A total of 24 SPF-grade SD rats (aged 4&#xa0;weeks, 60&#x2212;80&#xa0;g) were purchased from the Henan Provincial Laboratory Animal Center. They were maintained in a spacious animal house and fed a standard mouse diet and water <italic>ad libitum</italic>. The feed and ultrapure water were kept for 1&#xa0;week, and after weighing, the rats were randomly divided into the control and T-2 toxin groups. The 12 rats were administered 4% absolute ethanol by gavage in the control group, and the 12 rats were administered T-2 toxin (100&#xa0;ng/g; BW/day; J&#x26;K Scientific LLC, USA) by gavage in the T-2 toxin group (<xref ref-type="bibr" rid="B38">Yu et al., 2022</xref>). During this period, the weight and other indicators of their growth and development were recorded. After treatment for 1 month, three rats in each group were anesthetized with urethane, and three articular cartilages were used to extract RNA. All animal studies were reviewed and approved by the Animal Ethics Research Committee of Zhengzhou University (ZZUIRB 2021-69).</p>
</sec>
<sec id="s2-2">
<title>Hematoxylin&#x2013;eosin (H&#x26;E) staining</title>
<p>After the rats were sacrificed, the knee joints were collected, fixed in 4% paraformaldehyde for 24&#xa0;h, and decalcified with 10% EDTA for 1&#xa0;month. The decalcified knee joints were embedded in paraffin and sectioned. The tissue sections were stained with H&#x26;E. Finally, the stained tissue sections were dehydrated and sealed with neutral gum, and the collected images were observed under a microscope.</p>
</sec>
<sec id="s2-3">
<title>Total RNA extraction</title>
<p>RNA was extracted using the TRIzol reagent (Thermo Fisher Scientific, USA) for RNA sequencing (RNA-seq). After collecting the RNA samples, the concentration was accurately quantified using Qubit, and the ratios of OD<sub>260/280</sub> and OD<sub>260/230</sub> were detected using a Nanodrop 2000 spectrophotometer (Thermo Fisher Scientific, USA). Then, the degree of RNA degradation was detected by agarose gel electrophoresis and an Agilent 2100 Bioanalyzer (Agilent Technologies, USA).</p>
</sec>
<sec id="s2-4">
<title>Construction of the DNA-specific library</title>
<p>An appropriate amount of total RNA was used to remove rRNA, and the RNA was purified and fragmented. Reverse transcription was used to synthesize the first strand cDNA and second strand cDNA. Next, a single adenylate &#x201c;A&#x201d; was added to the 3&#x2032; ends on both sides of the modified double-stranded cDNA to prevent self-ligation of the flat ends between the cDNA fragments. Ligation buffer and a double-stranded sequencing linker were added to the aforementioned reaction system, and the Illumina sequencing linker was connected to both ends of the DNA library using T4 DNA ligase (NEB, UK). The Agencourt SPRI select Nucleic Acid Fragment Screening kit was used to screen the fragment size while the library was being purified, and a two-step screening method was used to select the original library with a fragment peak of 300&#xa0;bp. In a 50-&#x3bc;l reaction system, high fidelity polymerase was used to amplify the original library to ensure a sufficient total number of libraries. The constructed library was qualified using Qubit and an Agilent 2100 Bioanalyzer (Agilent Technologies, USA) and then sequenced using an Illumina HiSeq 2500 System (Illumina, USA).</p>
</sec>
<sec id="s2-5">
<title>Differential expression mRNA analysis</title>
<p>Deseq2 software was used to analyze differentially expressed mRNA in the T-2 toxin and control groups. <italic>p</italic>-values &#x3c;0.05 and &#x7c; log<sub>2</sub> (fold change) &#x7c; &#x3e; 1 were considered differentially expressed mRNAs, log<sub>2</sub> (fold change) &#x3e; 1 was labeled as an upregulated mRNA, and log<sub>2</sub> (fold change) &#x3c; &#x2212;1 was labeled as a downregulated mRNA.</p>
</sec>
<sec id="s2-6">
<title>Enrichment analysis</title>
<p>Gene Ontology (GO) is an international standard classification system for gene functions. Through GO enrichment analysis, significantly differentially expressed genes were classified according to cellular components, molecular functions, and biological processes. KEGG (Kyoto Encyclopedia of Genes and Genomes) is a vital public database of classical pathways for experimental verification. Pathway enrichment analysis takes the KEGG pathway as the unit and applies a hypergeometric test to determine which pathways are significantly enriched in a specific gene set compared to the whole genome background. The analysis was based on differentially expressed genes marked as up and down, and an online tool (<ext-link ext-link-type="uri" xlink:href="https://www.bioinformatics.com.cn">https://www.bioinformatics.com.cn</ext-link>) was used to perform GO and KEGG enrichment analyses (<xref ref-type="bibr" rid="B21">Luo &#x26; Brouwer, 2013</xref>).</p>
</sec>
<sec id="s2-7">
<title>T-2 toxin-related genes from GeneCards</title>
<p>The T-2 toxin-related genes were obtained from the GeneCards (<ext-link ext-link-type="uri" xlink:href="https://www.genecards.org/">https://www.genecards.org/</ext-link>) database. The relevance scores of &#x3e;5 were used as the screening criteria (<xref ref-type="bibr" rid="B27">Safran et al., 2022</xref>). KEGG pathways were plotted using a free online platform for data analysis and visualization (<ext-link ext-link-type="uri" xlink:href="https://www.bioinformatics.com.cn">https://www.bioinformatics.com.cn</ext-link>).</p>
</sec>
<sec id="s2-8">
<title>Immunohistochemical (IHC) staining</title>
<p>The dewaxed and rehydrated tissue sections were placed in a repair box filled with citric acid (pH 6.0) antigen repair buffer. Next, 3% hydrogen peroxide was used to inhibit the endogenous peroxidase activity. After blocking with 3% bovine serum albumin for 30&#xa0;min at room temperature, the slices were incubated with primary anti-Mmp and anti-Tnf antibodies (1:500 dilution, Wuhan Servicebio Biotechnology) overnight at 4&#xb0;C and then incubated with horseradish peroxidase&#x2013;conjugated secondary antibodies for 50&#xa0;min at room temperature. Next, the slices were washed with phosphate buffered saline, developed, and sealed after re-staining the nuclei with hematoxylin. Semi-quantitative analysis of the acquired images was performed using Image Pro Plus 6.0.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Influence of cartilage tissues treated with T-2 toxin</title>
<p>The H&#x26;E staining results show the histopathologic changes of rat cartilage tissues in each group (<xref ref-type="fig" rid="F1">Figure 1</xref>). In the control group, chondrocytes were abundant and arranged in an orderly manner from top to bottom, and the morphology of the cells and nuclei was normal. Abnormalities were not observed in the control group. In the T-2 toxin group, the number of cells decreased significantly, and the arrangement of chondrocytes became disordered. The hypertrophic chondrocytes were clustered, and the physalide phenomenon caused by the loss of the nucleus also appeared.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Pathological changes of rat cartilage tissues in the T-2 toxin and control groups using H&#x26;E staining. The black arrows indicated chondrocytes without the nucleus.</p>
</caption>
<graphic xlink:href="fgene-13-1079739-g001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>Identification of differentially expressed mRNA</title>
<p>Analyses of differentially expressed mRNAs showed that 284 significant differentially expressed mRNAs were identified in the T-2 group compared to the control group. Of these, 195 mRNAs were significantly upregulated, and 89 mRNAs were downregulated (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Cluster analysis was performed to identify differentially expressed mRNAs between the T-2 and control groups. In <xref ref-type="fig" rid="F2">Figure 2B</xref>, each column represents a different sample, and each row represents the expression levels of mRNA in different colors: up (red) or down (green).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Differentially expressed mRNA analysis and cluster analysis. <bold>(A)</bold> Volcano of differentially expressed mRNA in the T-2 toxin group compared with the control group. Green represents downregulated mRNA, and orange represents upregulated mRNA. <bold>(B)</bold> Hierarchical clustering of differentially expressed mRNA in the T-2 toxin group compared with the control group. Green represents downregulated mRNA, and red represents upregulated mRNA.</p>
</caption>
<graphic xlink:href="fgene-13-1079739-g002.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>GO analysis</title>
<p>The GO results were divided into three categories (namely, biological process, cellular component, and molecular function). As shown in <xref ref-type="fig" rid="F3">Figure 3</xref>, the top immune-related biological processes were the regulation of hormone secretion, regulation of peptide hormone secretion, regulation of transcription involved in cell fate commitment, positive regulation of the small molecule metabolic process, and response to activity. The top immune-related cellular components were the ATPase-dependent transmembrane transport complex, an anchored component of the plasma membrane, the cation-transporting ATPase complex, the recycling endosome, and the apical part of the cell. The top immune-related molecular functions were receptor&#x2013;ligand activity, signaling receptor activator activity, receptor regulator activity, sodium channel regulator activity, iron ion binding, and cytokine activity.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Gene Ontology (GO) functional classification. The significant GO terms of differentially expressed genes in the T-2 toxin group compared with the control group. The orange, green, and blue bars represent the biological process, cellular component, and molecular function, respectively.</p>
</caption>
<graphic xlink:href="fgene-13-1079739-g003.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>KEGG pathway analysis</title>
<p>The KEGG pathway enrichment analysis identified significant pathways. According to the enrichment score, the top 10 significant pathways were the adipocytokine signaling pathway, the PPAR signaling pathway, the IL-17 signaling pathway, alcoholic liver disease, protein digestion and absorption, proximal tubule bicarbonate reclamation, insulin resistance, the TNF signaling pathway, type II diabetes mellitus, and cholesterol metabolism (<xref ref-type="fig" rid="F4">Figure 4A</xref>). <xref ref-type="fig" rid="F4">Figure 4B</xref> shows the relationship between significant pathways and enriched genes, and different colors represent different pathways. The path diagrams of the IL-17 signaling pathway (<xref ref-type="fig" rid="F5">Figure 5</xref>) and the TNF signaling pathway (<xref ref-type="fig" rid="F6">Figure 6</xref>) were significantly correlated with the damaged articular cartilage exposed to T-2 toxin. Seven identified genes were enriched in the IL-17 and TNF signaling pathways (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>KEGG pathway enrichment analysis (top 10). <bold>(A)</bold> Top 10 significant KEGG pathways of differentially expressed genes in the T-2 toxin group compared with the control group. <bold>(B)</bold> Relationship between significant pathways and enriched genes, and different colors represent different pathways. <italic>p</italic>-value &#x3c;0.05 was considered significant pathways.</p>
</caption>
<graphic xlink:href="fgene-13-1079739-g004.tif"/>
</fig>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Differentially expressed genes enriched in the path diagram of the IL-17 signaling pathway.</p>
</caption>
<graphic xlink:href="fgene-13-1079739-g005.tif"/>
</fig>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Differentially expressed genes enriched in the path diagram of the TNF signaling pathway.</p>
</caption>
<graphic xlink:href="fgene-13-1079739-g006.tif"/>
</fig>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Differentially expressed genes enriched in the IL-17 and TNF and signaling pathways.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Gene symbol</th>
<th align="left">Gene name</th>
<th align="left">log<sub>2</sub> fold change</th>
<th align="left">
<italic>p</italic>-value</th>
<th align="left">Type</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Mmp3</td>
<td align="left">Matrix metallopeptidase 3</td>
<td align="left">1.10</td>
<td align="left">5.38 &#xd7; 10<sup>&#x2212;5</sup>
</td>
<td align="left">Up</td>
</tr>
<tr>
<td align="left">Tnf</td>
<td align="left">Tumor necrosis factor</td>
<td align="left">2.03</td>
<td align="left">2.08 &#xd7; 10<sup>&#x2212;2</sup>
</td>
<td align="left">Up</td>
</tr>
<tr>
<td align="left">Mapk10</td>
<td align="left">Mitogen-activated protein kinase 10</td>
<td align="left">2.23</td>
<td align="left">1.21 &#xd7; 10<sup>&#x2212;2</sup>
</td>
<td align="left">Up</td>
</tr>
<tr>
<td align="left">Ccl11</td>
<td align="left">C-C motif chemokine ligand 11</td>
<td align="left">2.26</td>
<td align="left">1.34 &#xd7; 10<sup>&#x2212;2</sup>
</td>
<td align="left">Up</td>
</tr>
<tr>
<td align="left">Creb5</td>
<td align="left">cAMP-responsive element-binding protein 5</td>
<td align="left">1.09</td>
<td align="left">5.28 &#xd7; 10<sup>&#x2212;13</sup>
</td>
<td align="left">Up</td>
</tr>
<tr>
<td align="left">Cxcl2</td>
<td align="left">C-X-C motif chemokine ligand 2</td>
<td align="left">&#x2212;2.77</td>
<td align="left">3.34 &#xd7; 10<sup>&#x2212;4</sup>
</td>
<td align="left">Down</td>
</tr>
<tr>
<td align="left">Cebpb</td>
<td align="left">CCAAT/enhancer-binding protein-beta</td>
<td align="left">&#x2212;1.26</td>
<td align="left">6.55 &#xd7; 10<sup>&#x2212;3</sup>
</td>
<td align="left">Down</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3-5">
<title>T-2 toxin-related gene enrichment analysis</title>
<p>In the GeneCards database, the 13 identified T-2 toxin-related genes (<xref ref-type="table" rid="T2">Table 2</xref>) were screened with a score greater than 5. KEGG pathways were enriched using an online tool (<ext-link ext-link-type="uri" xlink:href="https://www.bioinformatics.com.cn">https://www.bioinformatics.com.cn</ext-link>). The IL-17 signaling pathway was significantly correlated with T-2 toxin (<xref ref-type="fig" rid="F7">Figure 7A</xref>). The enriched genes (TNF, IL1B, IL2, IL6, and CXCL8) are presented in <xref ref-type="fig" rid="F7">Figure 7B</xref>.</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>T-2 toxin-related genes from GeneCards based on the score more than 5.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Gene symbol</th>
<th align="left">Gene name</th>
<th align="left">GIFtS</th>
<th align="left">GC ID</th>
<th align="left">Score</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">TNF</td>
<td align="left">Tumor necrosis factor</td>
<td align="left">54</td>
<td align="left">GC06P087731</td>
<td align="left">11.21</td>
</tr>
<tr>
<td align="left">IL1B</td>
<td align="left">Interleukin 1 beta</td>
<td align="left">50</td>
<td align="left">GC02M112829</td>
<td align="left">10.09</td>
</tr>
<tr>
<td align="left">ALB</td>
<td align="left">Albumin</td>
<td align="left">52</td>
<td align="left">GC04P073397</td>
<td align="left">8.36</td>
</tr>
<tr>
<td align="left">IL2</td>
<td align="left">Interleukin 2</td>
<td align="left">51</td>
<td align="left">GC04M122451</td>
<td align="left">7.99</td>
</tr>
<tr>
<td align="left">FURIN</td>
<td align="left">Furin, paired basic amino acid cleaving enzyme</td>
<td align="left">50</td>
<td align="left">GC15P090868</td>
<td align="left">7.68</td>
</tr>
<tr>
<td align="left">IL6</td>
<td align="left">Interleukin 6</td>
<td align="left">53</td>
<td align="left">GC07P022725</td>
<td align="left">7.56</td>
</tr>
<tr>
<td align="left">CXCL8</td>
<td align="left">C-X-C motif chemokine ligand 8</td>
<td align="left">44</td>
<td align="left">GC04P073740</td>
<td align="left">7.29</td>
</tr>
<tr>
<td align="left">PARP1</td>
<td align="left">Poly (ADP-ribose) polymerase 1</td>
<td align="left">53</td>
<td align="left">GC01M226360</td>
<td align="left">6.45</td>
</tr>
<tr>
<td align="left">BCL2</td>
<td align="left">BCL2 apoptosis regulator</td>
<td align="left">53</td>
<td align="left">GC18M063123</td>
<td align="left">6.15</td>
</tr>
<tr>
<td align="left">EGF</td>
<td align="left">Epidermal growth factor</td>
<td align="left">54</td>
<td align="left">GC04P109912</td>
<td align="left">5.82</td>
</tr>
<tr>
<td align="left">MAPK1</td>
<td align="left">Mitogen-activated protein kinase 1</td>
<td align="left">54</td>
<td align="left">GC22M021759</td>
<td align="left">5.67</td>
</tr>
<tr>
<td align="left">CASP3</td>
<td align="left">Caspase 3</td>
<td align="left">52</td>
<td align="left">GC04M184627</td>
<td align="left">5.48</td>
</tr>
<tr>
<td align="left">CASP9</td>
<td align="left">Caspase 9</td>
<td align="left">49</td>
<td align="left">GC01M015491</td>
<td align="left">5.43</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Abbreviation: GIFtS, GeneCards Inferred Functionality Score; GC ID, GeneCards identifiers.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>KEGG pathway enrichment analysis (top 10). <bold>(A)</bold> Top 10 significant KEGG pathways of T-2 toxin-related genes. <bold>(B)</bold> Relationship between significant pathways and enriched genes, and different colors represent different pathways. <italic>p</italic>-value &#x3c;0.05 was considered significant pathways.</p>
</caption>
<graphic xlink:href="fgene-13-1079739-g007.tif"/>
</fig>
</sec>
<sec id="s3-6">
<title>IHC staining</title>
<p>The expression levels of Mmp3 and Tnf proteins were determined by IHC staining. As shown in <xref ref-type="fig" rid="F8">Figure 8</xref>, the positive expression of Mmp3 and Tnf proteins in the T-2 toxin group was significantly higher than that in the control group, and the expression levels of Mmp3 and Tnf proteins were increased in the T-2 toxin group (<italic>p</italic> &#x3c; 0.05).</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Immunohistochemistry staining of knee joint cartilage of rats in the T-2 toxin and control groups. All data represent mean &#xb1; SD, and &#x2a;<italic>p</italic> &#x3c; 0.05 was considered significant.</p>
</caption>
<graphic xlink:href="fgene-13-1079739-g008.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>It is well known that T-2 toxin is harmful to human health. T-2 toxins can cause cytotoxicity, genotoxicity, immunotoxicity, hepatotoxicity, gastrointestinal toxicity, skeletal toxicity, nephrotoxicity, reproductive toxicity, and neurotoxicity. It damages the immune organs, such as the liver, digestive tract, bones, and kidneys, leading to pathological changes and impaired physiological functions of these organs (<xref ref-type="bibr" rid="B15">Li S. J. et al., 2022</xref>). Furthermore, the T-2 toxin has been reported to induce oxidative stress and inflammation, thereby causing organ toxicity. Studies have confirmed that T-2 toxin can increase the excessive production of nitric oxide by increasing various inflammatory cytokines, thus leading to mitochondrial damage and redox imbalance, further inducing apoptosis (<xref ref-type="bibr" rid="B19">Liu et al., 2017</xref>). Although T-2 toxin is an environmental risk factor for KBD, the potential mechanism by which T-2 toxin damages articular cartilage remains unknown. In the current study, a series of experiments was carried out to clarify the potential mechanism of damaged cartilage induced by T-2 toxin.</p>
<p>Our results demonstrated T-2 toxin-induced pathological changes in the articular cartilage of rats. The KEGG pathway enrichment results showed that IL-17 and TNF signaling pathways were related to inflammation. In addition, T-2 toxin-related genes obtained from GeneCards were used for enrichment analysis, and it was found that the IL-17 signaling pathway was also significantly expressed. These results indicated that the inflammatory reaction may play an important role in the damaged joint cartilage of rats induced by T-2 toxin. In addition, Mmp3, Tnf, Mapk10, Ccl11, Creb5, Cxcl2, and Cebpb were significantly enriched in the IL-17 and TNF signaling pathways.</p>
<p>Interleukin-17 (IL-17) is a member of a new family of inflammatory cytokines (<xref ref-type="bibr" rid="B2">Amatya et al., 2017</xref>). IL-17 is associated with many inflammatory diseases, such as rheumatoid arthritis, asthma, lupus, and allograft rejection (<xref ref-type="bibr" rid="B1">Aggarwal &#x26; Gurney, 2002</xref>; <xref ref-type="bibr" rid="B24">Moseley et al., 2003</xref>; <xref ref-type="bibr" rid="B11">Kolls &#x26; Lind&#xe9;n, 2004</xref>). IL-17 receptors are widely distributed in various tissues and participate in the activation of transcription factor NF-&#x3ba;B and the kinase JNK pathway, which are related to inflammatory and immune diseases (<xref ref-type="bibr" rid="B28">Schwandner et al., 2000</xref>; <xref ref-type="bibr" rid="B24">Moseley et al., 2003</xref>). Tumor necrosis factor (TNF) is mainly produced by activated macrophages and T lymphocytes, and proto-TNF is expressed on the plasma membrane, where it can be cleaved by matrix metalloproteinases (MMPs) in the extracellular region, thus releasing its soluble form (<xref ref-type="bibr" rid="B3">Bradley, 2008</xref>). It is well known that pro-inflammatory cytokines including IL-1b, TNF, and IL-6 promote cartilage degradation by stimulating the production of MMPs (<xref ref-type="bibr" rid="B39">Zhou et al., 2014</xref>). A proteinase activation cascade is likely initiated by plasmin, the product of plasminogen activator activity, which in turn activates latent stromelysin (MMP3), an activator of latent collagenases (<xref ref-type="bibr" rid="B8">Goldring, 2000</xref>). Activation of the NLRP3 inflammasome leads to a wide range of immune responses, including the production of pro-inflammatory cytokines and chemokines and cell death (<xref ref-type="bibr" rid="B33">Wree et al., 2013</xref>; <xref ref-type="bibr" rid="B4">Broderick et al., 2015</xref>). Studies have shown the liver inflammation and fibrosis induced by the NLRP3 inflammasome were affected by IL-17 and TNF, and the effect of TNF was more significant (<xref ref-type="bibr" rid="B34">Wree et al., 2018</xref>). Therefore, some inflammasomes in the articular cartilage may also be affected by IL-17 and TNF, which leads to the enhancement of the inflammatory response. MAPK10 is a member of the Jun N-terminal kinase subgroup in the mitogen-activated protein kinase superfamily and is involved in multiple signaling pathways in key physiological processes, such as apoptosis, differentiation, and proliferation (<xref ref-type="bibr" rid="B5">Davis, 2000</xref>; <xref ref-type="bibr" rid="B35">Yan et al., 2018</xref>). Some studies have shown that MAPK10 plays a central role in atrial fibrillation in mice, and MAPK10 knockout can significantly reduce atrial inflammation (<xref ref-type="bibr" rid="B18">Liu et al., 2022</xref>). The chemokine C-C motif ligand 11 (CCL11) is a member of the CC chemokine family and is produced by connective tissue cells and leukocytes in the human body (<xref ref-type="bibr" rid="B30">Wakabayashi et al., 2021</xref>). CCL11 can induce the migration of many types of leukocytes, including eosinophils, basophils, macrophages, and dendritic cells (<xref ref-type="bibr" rid="B7">Elsner et al., 1996</xref>; <xref ref-type="bibr" rid="B25">Peled et al., 1998</xref>; <xref ref-type="bibr" rid="B23">Menzies-Gow et al., 2002</xref>). The chemokine CXCL2 is induced by macrophage toll-like receptor signal transduction and is responsible for the recruitment of neutrophils, which is the most important step in response to pathogens (<xref ref-type="bibr" rid="B6">De Filippo et al., 2008</xref>). Our transcriptome sequencing results showed that the expression of Cxcl2 was downregulated. Therefore, it can be speculated that T-2 toxin may reduce the ability of rats to resist pathogens by inhibiting the expression of Cxcl2.</p>
<p>In addition, the IHC analysis results showed that the expression levels of Mmp3 and Tnf proteins in the T-2 toxin group were significantly higher than those in the control group. This indicated that T-2 toxin can activate the expression of Mmp3 and Tnf, which is consistent with the RNA-seq results. Generally, TNF first binds to its receptors and then transmits molecular signals for biological functions such as inflammation and cell death. It has also been shown that T-2 toxin can increase the level of TNF (<xref ref-type="bibr" rid="B16">Lin et al., 2019</xref>). TNF can activate the immune system, but inappropriate or excessive production of TNF may be harmful and lead to rheumatoid arthritis, inflammatory bowel disease, psoriasis arthritis, psoriasis, and non-infectious uveitis (<xref ref-type="bibr" rid="B10">Jang et al., 2021</xref>). TNF inhibitors have been successfully developed and applied in the clinical treatment of autoimmune diseases such as Crohn&#x2019;s disease and rheumatoid arthritis (<xref ref-type="bibr" rid="B26">Raychaudhuri &#x26; Raychaudhuri, 2009</xref>; <xref ref-type="bibr" rid="B17">Lis et al., 2014</xref>). MMP3 is a protease that is synthesized and secreted by synovial fibroblasts and chondrocytes, and it can be used as a reliable marker of rheumatoid arthritis (<xref ref-type="bibr" rid="B12">Lerner et al., 2018</xref>). The MMP3 enzyme can degrade a variety of collagen, proteoglycans, fibronectin, laminin, and elastin. In addition, it can activate other MMPs, such as MMP-1, MMP-7, and MMP-9. Therefore, MMP3 plays a key role in connective tissue remodeling (<xref ref-type="bibr" rid="B12">Lerner et al., 2018</xref>).</p>
<p>In this study, RNA-seq was used to explore the mechanism of damaged cartilage induced by T-2 toxin, which may enhance the inflammatory response by activating the IL-17 and TNF signaling pathways, resulting in an abnormal inflammatory response in chondrocytes and cartilage injury. However, several limitations need to be addressed. First, an animal model was used to study the inflammatory response involved in damaged articular cartilage, and this needs to be validated in the cartilage of KBD patients. Second, further molecular experiments should be performed to validate the IL-17 and TNF signaling pathways. Despite these limitations, our results provided new insight for further understanding the mechanism of damaged articular cartilage induced by T-2 toxin.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s11">Supplementary Material</xref>; further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6">
<title>Ethics statement</title>
<p>All animal studies were reviewed and approved by the Animal Ethics Research Committee of Zhengzhou University (ZZUIRB 2021-69).</p>
</sec>
<sec id="s7">
<title>Author contributions</title>
<p>LS, JW, and YF contributed to design the study. LS, QL, HY, and QW conducted the experiments. LS and QL drafted the manuscript and visualized the results. HY and QW conducted bioinformatics analysis. JW and YF critically reviewed the manuscript. All authors contributed to the manuscript revision and approved the submitted version.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>This work was funded by the Foreign Experts Program of Henan Province (HNGD2021032).</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2022.1079739/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fgene.2022.1079739/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.xlsx" id="SM1" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aggarwal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gurney</surname>
<given-names>A. L.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>IL-17: Prototype member of an emerging cytokine family</article-title>. <source>J. Leukoc. Biol.</source> <volume>71</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.71.1.1</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amatya</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Garg</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Gaffen</surname>
<given-names>S. L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>IL-17 signaling: The yin and the Yang</article-title>. <source>Trends Immunol.</source> <volume>38</volume> (<issue>5</issue>), <fpage>310</fpage>&#x2013;<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1016/j.it.2017.01.006</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bradley</surname>
<given-names>J. R.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>TNF-mediated inflammatory disease</article-title>. <source>J. Pathol.</source> <volume>214</volume> (<issue>2</issue>), <fpage>149</fpage>&#x2013;<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1002/path.2287</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Broderick</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>De Nardo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Franklin</surname>
<given-names>B. S.</given-names>
</name>
<name>
<surname>Hoffman</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Latz</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>The inflammasomes and autoinflammatory syndromes</article-title>. <source>Annu. Rev. Pathol.</source> <volume>10</volume>, <fpage>395</fpage>&#x2013;<lpage>424</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-pathol-012414-040431</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davis</surname>
<given-names>R. J.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Signal transduction by the JNK group of MAP kinases</article-title>. <source>Cell</source> <volume>103</volume> (<issue>2</issue>), <fpage>239</fpage>&#x2013;<lpage>252</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(00)00116-1</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Filippo</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Henderson</surname>
<given-names>R. B.</given-names>
</name>
<name>
<surname>Laschinger</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hogg</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Neutrophil chemokines KC and macrophage-inflammatory protein-2 are newly synthesized by tissue macrophages using distinct TLR signaling pathways</article-title>. <source>J. Immunol.</source> <volume>180</volume> (<issue>6</issue>), <fpage>4308</fpage>&#x2013;<lpage>4315</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.180.6.4308</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elsner</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>H&#xf6;chstetter</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kimmig</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kapp</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Human eotaxin represents a potent activator of the respiratory burst of human eosinophils</article-title>. <source>Eur. J. Immunol.</source> <volume>26</volume> (<issue>8</issue>), <fpage>1919</fpage>&#x2013;<lpage>1925</lpage>. <pub-id pub-id-type="doi">10.1002/eji.1830260837</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldring</surname>
<given-names>M. B.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Osteoarthritis and cartilage: The role of cytokines</article-title>. <source>Curr. Rheumatol. Rep.</source> <volume>2</volume> (<issue>6</issue>), <fpage>459</fpage>&#x2013;<lpage>465</lpage>. <pub-id pub-id-type="doi">10.1007/s11926-000-0021-y</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>F. L.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Lammi</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Recent advances in the research of an endemic osteochondropathy in China: Kashin-Beck disease</article-title>. <source>Osteoarthr. Cartil.</source> <volume>22</volume> (<issue>11</issue>), <fpage>1774</fpage>&#x2013;<lpage>1783</lpage>. <pub-id pub-id-type="doi">10.1016/j.joca.2014.07.023</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname>
<given-names>D. I.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>H. R.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>T. B.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>The role of tumor necrosis factor Alpha (TNF-&#x3b1;) in autoimmune disease and current TNF-&#x3b1; inhibitors in therapeutics</article-title>. <source>Int. J. Mol. Sci.</source> <volume>22</volume> (<issue>5</issue>), <fpage>2719</fpage>. <pub-id pub-id-type="doi">10.3390/ijms22052719</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kolls</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Lind&#xe9;n</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Interleukin-17 family members and inflammation</article-title>. <source>Immunity</source> <volume>21</volume> (<issue>4</issue>), <fpage>467</fpage>&#x2013;<lpage>476</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2004.08.018</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lerner</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Neidh&#xf6;fer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Reuter</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Matthias</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>MMP3 is a reliable marker for disease activity, radiological monitoring, disease outcome predictability, and therapeutic response in rheumatoid arthritis</article-title>. <source>Best. Pract. Res. Clin. Rheumatol.</source> <volume>32</volume> (<issue>4</issue>), <fpage>550</fpage>&#x2013;<lpage>562</lpage>. <pub-id pub-id-type="doi">10.1016/j.berh.2019.01.006</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>The effects of T-2 toxin on the prevalence and development of kashin-beck disease in China: A meta-analysis and systematic review</article-title>. <source>Toxicol. Res.</source> <volume>5</volume> (<issue>3</issue>), <fpage>731</fpage>&#x2013;<lpage>751</lpage>. <pub-id pub-id-type="doi">10.1039/c5tx00377f</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H. N.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>B. M.</given-names>
</name>
<name>
<surname>Hua</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Le-Le</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Meng-Yuan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xiu-Juan</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2022a</year>). <article-title>YAP plays a protective role in T-2 toxin-induced inhibition of chondrocyte proliferation and matrix degradation</article-title>. <source>Toxicon.</source> <volume>215</volume>, <fpage>49</fpage>&#x2013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxicon.2022.06.005</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J. C.</given-names>
</name>
<etal/>
</person-group> (<year>2022b</year>). <article-title>Toxicity and detoxification of T-2 toxin in poultry</article-title>. <source>Food Chem. Toxicol.</source> <volume>169</volume>, <fpage>113392</fpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2022.113392</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>T-2 toxin inhibits the production of mucin via activating the IRE1/XBP1 pathway</article-title>. <source>Toxicology</source> <volume>424</volume>, <fpage>152230</fpage>. <pub-id pub-id-type="doi">10.1016/j.tox.2019.06.001</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lis</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kuzawi&#x144;ska</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Ba&#x142;kowiec-Iskra</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Tumor necrosis factor inhibitors - state of knowledge</article-title>. <source>Arch. Med. Sci.</source> <volume>10</volume> (<issue>6</issue>), <fpage>1175</fpage>&#x2013;<lpage>1185</lpage>. <pub-id pub-id-type="doi">10.5114/aoms.2014.47827</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Time series RNA-seq analysis identifies MAPK10 as a critical gene in diabetes mellitus-induced atrial fibrillation in mice</article-title>. <source>J. Mol. Cell. Cardiol.</source> <volume>168</volume>, <fpage>70</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2022.04.013</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Nitric oxide (NO)-mediated mitochondrial damage plays a critical role in T-2 toxin-induced apoptosis and growth hormone deficiency in rat anterior pituitary GH3 cells</article-title>. <source>Food Chem. Toxicol.</source> <volume>102</volume>, <fpage>11</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2017.01.017</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y. N.</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>Y. D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y. W.</given-names>
</name>
<name>
<surname>Mi</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Endoplasmic reticulum stress pathway mediates T-2 toxin-induced chondrocyte apoptosis</article-title>. <source>Toxicology</source> <volume>464</volume>, <fpage>152989</fpage>. <pub-id pub-id-type="doi">10.1016/j.tox.2021.152989</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Brouwer</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Pathview: An R/bioconductor package for pathway-based data integration and visualization</article-title>. <source>Bioinformatics</source> <volume>29</volume> (<issue>14</issue>), <fpage>1830</fpage>&#x2013;<lpage>1831</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btt285</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lutsky</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Mor</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yagen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Joffe</surname>
<given-names>A. Z.</given-names>
</name>
</person-group> (<year>1978</year>). <article-title>The role of T-2 toxin in experimental alimentary toxic aleukia: A toxicity study in cats</article-title>. <source>Toxicol. Appl. Pharmacol.</source> <volume>43</volume> (<issue>1</issue>), <fpage>111</fpage>&#x2013;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1016/s0041-008x(78)80036-2</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menzies-Gow</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ying</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sabroe</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Stubbs</surname>
<given-names>V. L.</given-names>
</name>
<name>
<surname>Soler</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>T. J.</given-names>
</name>
<etal/>
</person-group> (<year>2002</year>). <article-title>Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers</article-title>. <source>J. Immunol.</source> <volume>169</volume> (<issue>5</issue>), <fpage>2712</fpage>&#x2013;<lpage>2718</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.169.5.2712</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moseley</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Haudenschild</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Reddi</surname>
<given-names>A. H.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Interleukin-17 family and IL-17 receptors</article-title>. <source>Cytokine Growth Factor Rev.</source> <volume>14</volume> (<issue>2</issue>), <fpage>155</fpage>&#x2013;<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1016/s1359-6101(03)00002-9</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peled</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gonzalo</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Lloyd</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gutierrez-Ramos</surname>
<given-names>J. C.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>The chemotactic cytokine eotaxin acts as a granulocyte-macrophage colony-stimulating factor during lung inflammation</article-title>. <source>Blood</source> <volume>91</volume> (<issue>6</issue>), <fpage>1909</fpage>&#x2013;<lpage>1916</lpage>. <pub-id pub-id-type="doi">10.1182/blood.v91.6.1909.1909_1909_1916</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raychaudhuri</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Raychaudhuri</surname>
<given-names>S. K.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Biologics: Target-specific treatment of systemic and cutaneous autoimmune diseases</article-title>. <source>Indian J. dermatol.</source> <volume>54</volume> (<issue>2</issue>), <fpage>100</fpage>&#x2013;<lpage>109</lpage>. <pub-id pub-id-type="doi">10.4103/0019-5154.53175</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Safran</surname>
<given-names>M. R. N.</given-names>
</name>
<name>
<surname>Twik</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>BarShir</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Iny Stein</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Dahary</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Fishilevich</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>The GeneCards suite chapter</article-title>. <source>Pract. Guide Life Sci. Databases</source>, <fpage>27</fpage>&#x2013;<lpage>56</lpage>.</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwandner</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction</article-title>. <source>J. Exp. Med.</source> <volume>191</volume> (<issue>7</issue>), <fpage>1233</fpage>&#x2013;<lpage>1240</lpage>. <pub-id pub-id-type="doi">10.1084/jem.191.7.1233</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sokoloff</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>1988</year>). <article-title>Kashin-beck disease: Current status</article-title>. <source>Nutr. Rev.</source> <volume>46</volume> (<issue>3</issue>), <fpage>113</fpage>&#x2013;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1111/j.1753-4887.1988.tb05395.x</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wakabayashi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Isozaki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tsubokura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fukuse</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kasama</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Eotaxin-1/CCL11 is involved in cell migration in rheumatoid arthritis</article-title>. <source>Sci. Rep.</source> <volume>11</volume> (<issue>1</issue>), <fpage>7937</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-021-87199-7</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Endemic kashin-beck disease: A food-sourced osteoarthropathy</article-title>. <source>Semin. Arthritis Rheum.</source> <volume>50</volume> (<issue>2</issue>), <fpage>366</fpage>&#x2013;<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1016/j.semarthrit.2019.07.014</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L. H.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y. X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W. G.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>T-2 toxin induces degenerative articular changes in rodents: Link to kaschin-beck disease</article-title>. <source>Toxicol. Pathol.</source> <volume>39</volume> (<issue>3</issue>), <fpage>502</fpage>&#x2013;<lpage>507</lpage>. <pub-id pub-id-type="doi">10.1177/0192623310396902</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wree</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Broderick</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Canbay</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hoffman</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Feldstein</surname>
<given-names>A. E.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>From NAFLD to NASH to cirrhosis-new insights into disease mechanisms</article-title>. <source>Nat. Rev. Gastroenterol. Hepatol.</source> <volume>10</volume> (<issue>11</issue>), <fpage>627</fpage>&#x2013;<lpage>636</lpage>. <pub-id pub-id-type="doi">10.1038/nrgastro.2013.149</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wree</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>McGeough</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Inzaugarat</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Eguchi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schuster</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>C. D.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>NLRP3 inflammasome driven liver injury and fibrosis: Roles of IL-17 and TNF in mice</article-title>. <source>Hepatology</source> <volume>67</volume> (<issue>2</issue>), <fpage>736</fpage>&#x2013;<lpage>749</lpage>. <pub-id pub-id-type="doi">10.1002/hep.29523</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Thomson</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Role of stress kinase JNK in binge alcohol-evoked atrial arrhythmia</article-title>. <source>J. Am. Coll. Cardiol.</source> <volume>71</volume> (<issue>13</issue>), <fpage>1459</fpage>&#x2013;<lpage>1470</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2018.01.060</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z. W.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Detection report of T-2 toxin in staple food of patients in Kashin Beck disease area</article-title>. <source>Chin. J. Endemic Dis.</source> (<issue>03</issue>), <fpage>146</fpage>&#x2013;<lpage>149</lpage>.</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>An integrative analysis of DNA methylation and transcriptome showed the dysfunction of MAPK pathway was involved in the damage of human chondrocyte induced by T-2 toxin</article-title>. <source>BMC Mol. Cell Biol.</source> <volume>23</volume> (<issue>1</issue>), <fpage>4</fpage>. <pub-id pub-id-type="doi">10.1186/s12860-021-00404-3</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>F. F.</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>X. L.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>J. H.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Animal models of Kashin-Beck disease exposed to environmental risk factors: Methods and comparisons</article-title>. <source>Ecotoxicol. Environ. Saf.</source> <volume>234</volume>, <fpage>113419</fpage>. <pub-id pub-id-type="doi">10.1016/j.ecoenv.2022.113419</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Increased levels of IL-6, IL-1&#x3b2;, and TNF-&#x3b1; in Kashin-Beck disease and rats induced by T-2 toxin and selenium deficiency</article-title>. <source>Rheumatol. Int.</source> <volume>34</volume> (<issue>7</issue>), <fpage>995</fpage>&#x2013;<lpage>1004</lpage>. <pub-id pub-id-type="doi">10.1007/s00296-013-2862-5</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>